This site is intended for healthcare professionals only
LoginRegister
USFDA nod to Roche Gazyva/Gazyvaro for treatment of lupus nephritisRoche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma
Relief Sought for Small Retailers as GST 2.0 Sparks Losses in Pharma TradeGovt Eases MRP Revision Rules for Medical Devices Post GST Cut, Stickering Made Voluntary
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer new drug application for gadoquatrane accepted for review in China
JnJ Darzalex faspro approved by USFDA for high risk smoldering multiple myelomaJnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised...
Allahabad HC Grants Relief to Pharma Firm Against Tax NoticesAllahabad HC Grants Relief to Pharma Firm Against Tax Notices
No Trial Waiver: CDSCO Panel Directs Sun Pharma to Run Phase III Study for Somatropin Liquid Injection Citing Lack of India-Specific DataSun Pharma Told to Limit Phase III Revefenacin Study to Triple Therapy COPD Patients
Rajasthan Chemists Warn of Indefinite Strike Over Rs 880 Crore Unpaid Govt DuesRajasthan Chemists Warn of Indefinite Strike Over Rs 880 Crore Unpaid Govt Dues
KEAM 2025: Kerala Releases Third Phase Allotment List for B.Pharm AdmissionsKEAM 2025: Kerala Releases Third Phase Allotment List for B.Pharm Admissions
Lupin secures S&P Global ESG Score of 91 for 2025Lupin gets 4 USFDA observations for Pune Biotech facility
Bayer Lynkuet approved in EU for hot flashesBayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms
JnJ Simponi bags USFDA okay for pediatric ulcerative colitisJnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis
Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approvalMerck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval
X